Latest News and Press Releases
Want to stay updated on the latest news?
-
The analysis explores how AI-driven innovations are transforming skin disease detection, treatment planning and aesthetic dermatology procedures.
-
Four of Six Patients Participating in the Compassionate Use Program Were Classified as ‘Improved’ or ‘Significantly Improved’ from Baseline Assessment Across Key Clinical Endpoints All Six Patients...
-
KNOXVILLE, Tenn., June 08, 2026 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced that its 2026 annual stockholder meeting (the...
-
The report tracks key market indicators, sustainability trends, investment flows and innovation patterns shaping the global life sciences landscape.
-
Schaumburg, IL, May 26, 2026 (GLOBE NEWSWIRE) -- The American Society for Dermatologic Surgery (ASDS) is pleased to introduce a refreshed format for its DermSugery Digest Podcast. Led by host Naomi...
-
IRVINE, Calif., May 22, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Medical Services Organization providing management...
-
SCOTTSDALE, Ariz., May 19, 2026 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical,” “the Company,” “we” or “our”), a commercial-stage pharmaceutical company focused on...
-
Dublin, May 19, 2026 (GLOBE NEWSWIRE) -- The "Dermatology Collaboration and Licensing Deals 2016-2026" report has been added to ResearchAndMarkets.com's offering.The definitive benchmark for...
-
TORONTO, May 14, 2026 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory...
-
Total revenues for the first quarter ended March 31, 2026 increased 21% year-over-year to $16.0 million Emrosi® revenues were $6.3 million in the first quarter ended March 31, 2026 Cash position...